Pfizer pledged to invest in further trials quickly
At first glance, this might seem convenient and efficient
Ray EC, Boyd-Shiwarski CR, Liu P, Novacic D, Cassiman D
Retatrutide is a triple hormone receptor agonist, acting on three receptors simultaneously: GLP-1 (glucagon-like peptide-1) reduces appetite and slows gastric emptying GIP (glucose-dependent insulinotropic polypeptide) enhances insulin secretion and may improve fat metabolism Glucagon receptor increases energy expenditure and promotes fat breakdown It is worth noting that glucagon receptor agonism can, in isolation, raise blood glucose levels
Any changes in ED while using tirzepatide are likely due to its effects on weight, blood sugar, or general healthnot from a direct action on the penis or reproductive system